Artwork

Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

HER2 as a targetable biomarker in gastrointestinal oncology

35:30
 
Share
 

Manage episode 501182503 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

touchEXPERT FOCUS for touchONCOLOGY

Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches.

The experts

  • Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium
  • Prof. Florian Lordick, University of Leipzig, Leipzig, Germany

This touchPODCAST is for HCPs outside of the UK

This activity is funded by an independent medical education grant from AstraZeneca.

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website:
www.touchONCOLOGY.com

  continue reading

505 episodes

Artwork
iconShare
 
Manage episode 501182503 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

touchEXPERT FOCUS for touchONCOLOGY

Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches.

The experts

  • Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium
  • Prof. Florian Lordick, University of Leipzig, Leipzig, Germany

This touchPODCAST is for HCPs outside of the UK

This activity is funded by an independent medical education grant from AstraZeneca.

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website:
www.touchONCOLOGY.com

  continue reading

505 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play